This article discusses a study on the role of CCL19 and CCL21 in HIV infections through the promotion of inflammation. It examines the expression of both CCL21 and CCL19 in bone marrow mono-nuclear cells as well as mono-nuclear cells from peripheral blood mono-nuclear in HIV-infected patient before as well as during extremely active anti-retroviral therapies.